New Medical Device Market Entry Permit: KFDN Daily
South Korea Updates Medical Device Regulations for Safety, Innovation
Table of Contents
- South Korea Updates Medical Device Regulations for Safety, Innovation
- south Korea’s Medical Device Regulations: A deep Dive
- What’s New in South Korean Medical Device Regulations?
- Why Are these Changes happening Now?
- What Does “Enhanced Clinical Evaluation” mean?
- How Are Cybersecurity Measures Being Strengthened?
- How Will Approval for New Medical Devices Be Streamlined?
- Key Changes in South Korean Medical Device Regulations: A Summary
SEOUL, South Korea (May 1, 2025) – South Korea’s Ministry of Food and Drug Safety (MFDS) is implementing revisions to regulations governing medical devices, focusing on enhanced clinical evaluation, cybersecurity, and support for novel technologies. The changes, partially implemented April 30, aim to bolster public safety while fostering innovation in the medical device market, especially in areas like artificial intelligence.
Enhanced Clinical Evaluation for Market Entry
The MFDS, led by Director Oh Yoo-kyung, is prioritizing improvements to regulations to facilitate the entry of new medical technologies.A key component is the introduction of a refined clinical evaluation system for medical devices seeking rapid market access.
This initiative stems from the “Enhancement of the New Medical Device’s market Enrollment Procedure,” jointly announced in November of the previous year. The MFDS will designate specific items requiring enhanced clinical evaluation data, subject to approval by the Ministry of Health and Welfare for new medical technology assessments.
New medical technology assessment is a mandatory process for technologies not covered by health insurance to verify thier safety and effectiveness before entering the medical field.
clinical assessment involves a thorough review of clinical trials, literature, and practical experience, including potential side effects.
Previously, new medical technologies utilizing already-licensed devices could proceed after the new technology evaluation. However, the strengthened clinical assessment aims to address safety concerns and ensure innovative medical technologies can be safely and swiftly adopted.
Welfare Ordinance revision)”>Cybersecurity Measures Strengthened
The updated regulations also clarify requirements for cybersecurity review data submission. To mitigate risks associated with hacking and data breaches in medical devices using wired and wireless dialog, the MFDS has established a clear definition of cybersecurity.
Cybersecurity-related details must now be included in the “shape and structure” and “precautions for use” sections of permit applications. This provides a basis for submitting cybersecurity verification data,such as technical documents,during the examination process.
The MFDS defines cybersecurity as the protection of information and systems from unauthorized access, use, disclosure, disturbance, modification, or destruction.
Streamlined Approval for Novel Devices
The MFDS has also developed a plan to expedite the approval and review of new progress medical devices. Devices incorporating entirely new principles and intended uses will receive priority review during the permit submission process.
Moreover, the agency aims to protect intellectual property by limiting the approval and examination of subsequent products that are substantially equivalent to already-marketed, grade 3 and 4 new development medical devices. This measure is intended to incentivize innovation and protect developers’ investments.
south Korea’s Medical Device Regulations: A deep Dive
Are you interested in learning about the latest updates to medical device regulations in South Korea? This article provides a comprehensive overview, focusing on the key changes and their implications.
What’s New in South Korean Medical Device Regulations?
South Korea’s Ministry of Food and Drug Safety (MFDS) announced revisions to its medical device regulations on May 1, 2025. These updates,partially implemented on April 30th,focus on enhancing public safety and fostering innovation in the medical device market. The changes emphasize:
enhanced clinical evaluation
Strengthened cybersecurity measures
Support for novel technologies, notably in areas like artificial intelligence.
Why Are these Changes happening Now?
The MFDS, under the leadership of Director Oh Yoo-kyung, is prioritizing these improvements to facilitate the introduction of new medical technologies while addressing safety concerns. The goal is to balance innovation with public safety.
What Does “Enhanced Clinical Evaluation” mean?
How is clinical evaluation changing?
The MFDS is implementing a more thorough clinical evaluation system for new medical devices seeking market access. This means a more detailed review process.
This includes the assessment of clinical trials, literature, and practical experience, including potential side effects. Specific items requiring enhanced clinical evaluation data will be designated, subject to approval by the Ministry of Health and Welfare for new medical technology assessments.
what’s the goal of enhanced clinical evaluation?
The enhanced clinical evaluation aims to ensure that innovative medical technologies are adopted safely and swiftly. It helps address safety concerns and supports a streamlined approval process.
How Are Cybersecurity Measures Being Strengthened?
Why is cybersecurity important for medical devices?
With the increasing connectivity of medical devices, the risk of hacking and data breaches has grown. Hackers could access sensitive patient information or even control devices, with perhaps perilous consequences.
What is the MFDS doing to improve cybersecurity?
The updated regulations clearly define cybersecurity and clarify requirements for cybersecurity review data submission. details related to cybersecurity must now be included in the “shape and structure” and “precautions for use” sections of permit applications. This requirement provides a basis for submitting verification data, like technical documents, during the examination process.
How does the MFDS define cybersecurity?
The MFDS defines cybersecurity as the protection of information and systems from:
Unauthorized access
use
Disclosure
Disturbance
Modification
* Destruction
How Will Approval for New Medical Devices Be Streamlined?
What is the MFDS doing to expedite approvals?
The MFDS has developed a plan to expedite the approval and review of new, innovative medical devices. Devices incorporating wholly new principles and intended uses will receive priority review during the permit submission process.
How is the MFDS protecting intellectual property?
The agency aims to protect intellectual property by limiting the approval and examination of subsequent products that are substantially equivalent to already-marketed, grade 3 and 4 new growth medical devices. The goal is to incentivize innovation and protect the investments of developers.
Key Changes in South Korean Medical Device Regulations: A Summary
Here is a table summarizing the key changes implemented by the MFDS:
| Area of change | Description | Benefit/Impact |
| :———————— | :——————————————————————————————————————————————— | :————————————————————————————————————————————————— |
| Clinical Evaluation | Strengthened review process for new medical technologies, including thorough assessment of clinical trials and potential side effects. | Ensures the safe and swift introduction of new medical technologies entering the market.|
| Cybersecurity | Clearer requirements for cybersecurity review data, defining cybersecurity and requiring its consideration in permit applications. | Mitigates risks associated with hacking and data breaches, protecting patient data and device functionality |
| Novel Device Approval | Priority review for devices with entirely new principles and intended uses. | Accelerates the approval process for innovative technologies. |
| Intellectual Property Protection | Limitation on the approval of substantially equivalent products to incentivize innovation and protect developers’ investments (grades 3 and 4).| Encourages the development and commercialization of innovative medical devices, fostering a competitive market environment with greater innovation. |
This information is current as of the provided source material (may 1, 2025). However, it is advisable to regularly check official MFDS publications for any further updates or modifications.